Fibrocalculous pancreatic diabetes (FCPD) is an uncommon cause of diabetes, seen mainly in developing countries
Introduction
Fibrocalculous pancreatic diabetes (FCPD) 1 is an uncommon cause of diabetes, characterised by chronic pancreatitis of unknown origin and the presence of large intraductal pancreatic stones. 2, 3 Patients frequently have a low body mass and require insulin treatment but they rarely develop ketosis and frequently have a history of abdominal pain. 2, 4, 5 The aetiology of FCPD is likely to be multifactorial, involving both environmental and genetic factors . 2, [6] [7] [8] Our previous work in south Indians with FCPD, using case-control studies, reported an HLA-DQB1 restriction fragment length polymorphisms (RFLP) association with FCPD pain, 6 similar to that found in type 1 diabetes (T1DM). That study also found an association with the hypervariable region in the 5Ј flanking region of the insulin gene (INS), with 40% of FCPD patients possessing the class 3 allele compared with 9.5% of control subjects; similar to that found in type 2 diabetes (T2DM) in the same ethnic group. 6 Other case-control studies have also reported associations between the HLA and FCPD but not with the same HLA-DQB1 allele. 8, 9 For example in eastern Indian subjects from Cuttack an association was found between FCPD and HLA-DQ9 (A* 0201-B*0303); this was different to that found in T1DM and protein deficiency diabetes mellitus. 8 Despite these reported HLA associations there is little evidence to support FCPD being an autoimmune disease. For example, there is no increase in antibodies to islet cells or glutamic acid decarboxylase compared to a control population, 10 and the clinical picture is very different from T1DM. 2 As all case-control studies are inherently prone to hidden population stratification, which can lead to false results, the aim of the present study was to use a familybased study to investigate the association between genetic susceptibility to FCPD and with both HLA-DQB1 and the insulin gene. As tumour necrosis factor (TNF), located in the major histocompatibility complex (MHC) class IV region, is also a candidate gene for chronic pancreatitis by conceivably modulating the cytokine response to an environmental toxin causing pancreatitis, we also included markers for the tumour necrosis factorlymphotoxin (TNF-LT) locus.
Results
A significant association between FCPD and HLA-DQB1 was observed; overall allele wise P = 0.003 (Table 1) . Part of this association could be accounted for by the increased transmission of HLA-DQB1*0302 (P = 0.03) and the decreased transmission of DQB1*0202 (transmitted 15 times, not transmitted 29 times; P = 0.03). Although an association was found between FCPD and the biallelic TNFc locus (allele wise P = 0.037; TNFc1 transmitted 42 times, not transmitted 25 and vice versa for TNFc2) this was no longer significant when corrected for multiple comparisons (P = 0.15). No overall association was found between FCPD and TNFa or TNFd (allele wise P = 0.11 and 0.16 respectively). However, a trend for an association was seen between FCPD and individual alleles of TNFa and TNFd, known to be in linkage disequilibrium (LD) with TNFc1. In particular, TNFa13 was transmitted 22 times and not transmitted eight times (P = 0.01; Pc = 0.13) and TNFd7 was transmitted 18 times and not transmitted five (P = 0.007; Pc = 0.056). The −308 TNFA polymorphism was found in 13 of 134 parents (10%) and there was no excess transmission to affected offspring (transmitted six times, not transmitted seven times; P = 0.78). A total of 55 three-locus haplotypes, composed of TNFa, c and d alleles, were identified, many of which were unique to this ethnic group. Two closely related extended haplotypes (TNFa13, c1, d7, transmitted nine times and not transmitted twice) and TNFa13, c1, d6 (transmitted 13 times and not transmitted three times) showed a tendency to segregate with FCPD susceptibility; however due to the large number of haplotypes significant statistical analyses were not possible.
No association was found between FCPD and the HphI RFLP in the 5Ј regulatory region of the insulin gene; the ETDT revealed a significant overall allele wise association (P = 0.003) *transmission for individual alleles P = 0.03; all other comparisons non significant a7, c2, d5-HLA-DQB*0202 1 8 a7, c2, d6-HLA-DQB*0202 5 3 a13, c1, d6-HLA-DQB*0601 7 2 a13, c1, d7-HLA-DQB*0601 5 0
All these haplotypes carried −308G TNF polymorphism. Only haplotypes present in more than five of the total parents are recorded. Formal statistical analysis was not useful due to the large number of haplotypes (Ͼ50) in these families.
T2DM associated HphI allele (class III) was transmitted 23 and non-transmitted 16 times; P = 0.26). Sixty-seven families have 100% power to detect an association at the 5% level, based on our previous south Indian data.
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Discussion
We have confirmed that there is a significant MHC association with FCPD using a family-based study design in Bangladeshi subjects. We were unable to support our previous observation in south Indians of an association between FCPD and the insulin gene locus. 6 The HLA-DQB1 association found in this study is different to that found in eastern and south Indian populations. 6, 8, 9 The most marked difference is the non-transmission of HLA-DQ2, indicating that this allele protects from FCPD, in contrast to T1DM in which it is positively associated in many ethnic groups, including subjects from the Indian sub-continent. 8, 11 Furthermore three FCPD patients in this study were positive for the HLA-DQB1*0602 allele; this underlines the difference between genetic susceptibility to FCPD and T1DM, as the HLA-DQB1*0602 allele is extremely rare in cases of T1DM. A combination of HLA-DQB1 and TNF microsatellite typing also revealed that the A1, B8, DR3, DQB1*0201 extended haplotype (TNFa2, c1, d1), which is commonly associated with T1DM susceptibility in Caucasians 12 was rare in this population, and indeed was not seen in this collection of Bangladeshi FCPD families. In contrast HLA-DQB1*0202 was the most frequent of the HLA-DQB1*02 subtypes; furthermore it was present on the TNFa7, c2, d5, 308G haplotype (transmitted one, nontransmitted eight) and TNFa7, c2, d6, 308G haplotype (transmitted five, non-transmitted three). These haplotypes are also rarely found in European Caucasian populations and in particular TNFd6 and TNFd7 are rare alleles. 13, 14 In common with our previous results in south Indians we observed an association between FCPD and DQB1*0302; 6 this shows similarities to the genetic predisposition to T1DM. 11 We also report for the first time data on the TNF-LT locus and FCPD. Although the strength of the association was strongest for HLA-DQB1 compared with MHC Class IV genotypes, it is conceivable that susceptibility to FCPD is determined by extended haplotypes composed of MHC class II, III and IV markers. [15] [16] [17] To address this issue a larger number of families with this comparatively rare condition would need to be studied. As different TNF alleles have been associated with varying levels of TNF expression [18] [19] [20] it might be hypothesised that FCPD involves a disordered lymphokine response to an unknown environmental toxin leading to pancreatic autodigestion with deleterious consequences on both endocrine and exocrine systems.
We also found differences in TNF haplotype distribution in Bangladeshi subjects compared to European Caucasoid populations, as with the HLA-DQB1. For instance, the TNFa13, c1, d7, 308G haplotype is rare in European Caucasoid populations but was relatively common in the Bangladeshi subjects (data not presented). Furthermore, HLA-DQB1*0601 was found on both the TNFa13, c1, d7, 308G (transmitted five, not transmitted zero) and TNFa13, c1, d6, 308G (transmitted seven times, not transmitted two) haplotypes, in Bangladeshi FCPD subjects. As microsatellite DNA sequences mutate at rates several orders of magnitude higher than that of the bulk of DNA 21 it is possible that the TNFd locus has mutated relatively recently to produce these two haplotypes from an original single haplotype. In that case the transmission rate to affected offspring would be even more significant (transmitted 12 times, not transmitted three).
In contrast to our case-control study of south Indians, the family-based association method failed to find an association between FCPD and the insulin gene locus and in particular the T2DM associated class III HphI allele markers. 6, 22 Furthermore, there was no parent-of-origin effect in Bangladeshi patients with FCPD, unlike our recent findings using the same study design in British/Irish Caucasian patients with T2DM, in which we have demonstrated paternal inheritance of the class III HphI allele of the insulin gene markers. 22 This suggests that either our original south Indian case-control study was a false-positive or that the data reflect ethnic heterogeneity within the Indian sub-continent.
In conclusion the genetic predisposition to FCPD in Bangladeshi subjects has some determinants in common with (HLA-DQB1*0302 and TNFc1) and some that are different from T1DM (decreased transmission of HLA-DQ2).
Subjects, materials and methods
Sixty-seven Bangladeshi families consisting of a proband with FCPD and both parents were recruited from patients attending BIRDEM, Dhaka, Bangladesh. The diagnosis of FCPD was made according to the following internationally defined criteria; 2 presence of diabetes defined by WHO criteria, a history of recurrent abdominal pain from childhood, radiological or ultrasound evidence of pancreatic calculi in the absence of a history of alcoholism, hyperparathyroid disease or hepatobiliary disease. The mean age of the patients were 19.2 ± 5.0 years with an age of onset of diabetes of 18 ± 5 years and the mean body mass index at time of venesection was 15.9 ± 2.8 kg/m 2 . Ninety-seven percent of patients with FCPD were insulin treated and the remainder were on oral hypoglycaemic agents; none had a history of diabetic ketoacidosis.
DNA analysis
HLA-DQB1 typing was performed using specific primers allowing detection of eight groups of HLA-DQB1 alleles. There were three groups of HLA-DQB1*03 alleles; DQB1* 0301/0304, DQB1*0302/0307 and DQB1*0303. Allele-specific typing was used to further differentiate HLA-DQB1* 02 into HLA-DQB1*0201/0203 or HLA-DQB1*0202, HLA-DQB1*0302/0307 into individual alleles and HLA-DQB1* 06 into HLA-DQB1*0601, *0602 and *0603. Three microsatellites, flanking and within the tumour necrosislymphotoxin (TNF-LT) locus, were studied (TNFa (13 alleles); TNFc (two alleles); TNFd (eight alleles)). 23 Fluorescent primers, polyacrylamide gel electrophoresis and an ABI373 DNA sequencer were used to genotype these patients. In addition a PCR-RFLP assay was used to type these families for the −308G/A TNF promoter polymorphism. 24 The Hph1 polymorphic restriction site in the hypervariable region (HVR) 5Ј to the insulin gene (INS) was also studied by the PCR-RFLP method using the restriction enzyme HphI. 25 Two alleles were detected of 
Statistical methods
The extended transmission disequilibrium test (ETDT) was used to investigate an association between HLA-DQB1, TNF-LT and insulin gene polymorphisms, and FCPD susceptibility. 26 If the overall allele-wise P value for an individual locus was not significant but there was statistical evidence of distorted transmission of individual alleles then the P value was corrected for the number of alleles at that locus. The overall allele-wise P value for TNFa, TNFc and TNFd and −308G/A TNF were multiplied by four since this locus has not been previously studied. We used the method of Risch and Merikanagas 27 and a multiplicative model to perform power calculations for the HLA-DQB1 and INS loci, based on disease gene frequencies from our previous case-control study in this population. 6 
